More recently, various uses of molecular profiling in breast cancer also includes ER and PR status testing, HER2/neu receptor status testing, and gene profile testing with, for example, MammaPrint [3] or Ocnotype DX [4, 5]. Here, ERBB2 is linked to breast carcinoma.